Simulation-based Inference for Cardiovascular Models
Antoine Wehenkel, Laura Manduchi, Jens Behrmann, Luca Pegolotti, Andrew C. Miller, Guillermo Sapiro, Ozan Sener, Marco Cuturi, Jörn-Henrik Jacobsen
TL;DR
This work reframes the inverse problem of inferring cardiovascular biomarkers from biosignals as simulation-based inference (SBI), yielding posterior distributions that capture multi-dimensional, individualized uncertainty. By applying neural posterior estimation to a full-body 1D cardiovascular simulator, the authors demonstrate population- and per-individual uncertainty analyses across measurement modalities and noise levels, uncovering multi-modal posteriors and sub-populations. In-silico results show differential information content across modalities (e.g., digital PPG vs. radial APW) and robust calibration of the posterior, while in-vivo transfer to MIMIC-III data reveals HR can be transferred reasonably well but LVET transfer is hindered by misspecification, motivating model refinement. The paper argues that SBI provides richer, more actionable insights for cardiovascular modeling and precision medicine than traditional sensitivity analyses, and it outlines future directions for joint-modality simulators and data integration to improve real-world applicability.
Abstract
Over the past decades, hemodynamics simulators have steadily evolved and have become tools of choice for studying cardiovascular systems in-silico. While such tools are routinely used to simulate whole-body hemodynamics from physiological parameters, solving the corresponding inverse problem of mapping waveforms back to plausible physiological parameters remains both promising and challenging. Motivated by advances in simulation-based inference (SBI), we cast this inverse problem as statistical inference. In contrast to alternative approaches, SBI provides \textit{posterior distributions} for the parameters of interest, providing a \textit{multi-dimensional} representation of uncertainty for \textit{individual} measurements. We showcase this ability by performing an in-silico uncertainty analysis of five biomarkers of clinical interest comparing several measurement modalities. Beyond the corroboration of known facts, such as the feasibility of estimating heart rate, our study highlights the potential of estimating new biomarkers from standard-of-care measurements. SBI reveals practically relevant findings that cannot be captured by standard sensitivity analyses, such as the existence of sub-populations for which parameter estimation exhibits distinct uncertainty regimes. Finally, we study the gap between in-vivo and in-silico with the MIMIC-III waveform database and critically discuss how cardiovascular simulations can inform real-world data analysis.
